BMCS Conformational Design in Drug Discovery 2024
Event
BMCS Conformational Design in Drug Discovery
Dates
Thursday 7th March 2024
Place
GSK Conference Centre, Stevenage, UK
Gunnels Wood Road
Stevenage
Hertfordshire
SG1 2FX
Synopsis
Conformational Design has played a key role in the medicinal chemistry of small molecule clinical candidates over the last 20 years. A key learning from multiple projects supported by experimental free ligand NMR solution conformations and protein-ligand X-ray structures is that the bioactive conformation of potent ligands is highly populated in solution. Ligand rigidification has been particularly successful in the design of selective and potent protein-protein interaction inhibitors and is becoming an increasingly important approach for PROTACs, molecular glues and other new modalities. This new RSC-BMCS event aims at building a community that shares conformational design strategies, technologies, and successful case studies. It will complement other rational drug design events and promote more successful research into future medicines.
Who should attend?
This symposium will provide great learnings for medicinal chemists, computational chemists, structural biologists, biophysicists and NMR analytical chemists with an academic or industry interest in drug discovery. Prior knowledge in conformational design will not be required.
Want to become a member?
To join the RSC in order to qualify for discounted registration fees at all RSC events, please follow this RSC link.
Bursaries
Bursary application submission is now closed.
Registration
Registration is now open. Please click here to register.
Call for Abstracts
Abstract submissions are now closed.
Important links and downloads
Twitter hashtag – #ConformationalDesign24
First announcement poster – click here to download
Second announcement poster – click here to download
Exhibition/Sponsor Opportunities
Exhibition Package is priced at £750 and includes:
– One stand personnel
– Stand space with a table and chairs
– Your logo and full promotional page in the pdf of the delegate handbook
– Your logo in the rolling slides, shown during the breaks
– Any additional stand personnel will have to be booked as delegates
Confirmed Speakers
Prof. Jan Kihlberg, Uppsala University
Gianni Chessari, Astex Pharmaceuticals
Elisabetta Chiarparin, Merck KGaA
Martin Packer, AstraZeneca UK
Prof. Alessio Ciulli, University of Dundee
Prof. Jonathan Essex, University of Southampton
Martin Watson, C4XD
Nichola Davies, AstraZeneca
Ian Wall, GlaxoSmithKline
Rodrigo Carbajo, J&J Innovative Medicine R&D
Meeting agenda
| 09:00 | Registration and Welcome Coffee |
| 09:50 | Welcome |
| 10:00 - 10:30 | Elisabetta Chiarparin, Merck KGaA The role of conformational selection in drug design |
| 10:30 - 11:00 | Martin Watson, C4XD The Importance of Experimental Conformational Analysis in Drug Design |
| 11:00 - 11:30 | Nichola Davies, AstraZeneca Structural determinants of orally bioavailable Ro5 and bRo5 drugs |
| 11:30 - 11:50 | Refreshment break |
| 11:50 - 12:20 | Rodrigo Carbajo, J&J Innovative Medicine A Database of Experimental Free-Ligand Conformations for Enhanced Drug Design |
| 12:20 - 12:50 | Jan Kihlberg, University of Uppsala Insight into PROTAC cell permeability and oral bioavailability |
| 12:50 - 13:05 | Flash Talk Presentations |
| 13:05 - 14:15 | Lunch break & Poster session |
| 14:15 - 14:45 | Gianni Chessari, Astex Pharmaceuticals Conformational studies and their impact in Structure-Based Drug Design |
| 14:45 - 15:15 | Jonathan Essex, University of Southampton How well do computer simulations reproduce molecular conformations? |
| 15:15 - 15:45 | Martin Packer, AstraZeneca Free energy perturbation as a conformational analysis tool |
| 15:45 - 16:05 | Refreshment break |
| 16:05 - 16:35 | Ian Wall, GSK Practical Applications of Conformational Design |
| 16:35 - 17:05 | Alessio Ciulli, University of Dundee How PROTAC degraders work: Molecular recognition and design principles |
| 17:05 - 17:10 | Close of conference |
Confirmed Exhibitors
We are grateful to our confirmed exhibitors for their valued support.
Sponsors
With thanks to our sponsors
Organising Committee
Markus Schade, AstraZeneca (Chair)
Chris Swain, Cambridge MedChem Consulting (Treasurer)
Tim Barrett, GSK
Sharan Bagal, AstraZeneca
Elisabetta Chiarparin, Merck KGaA
Mike Hann, GSK (Scientific Host)
Secretariat Contact and Further Information
Hg3 Conferences Ltd
+44 (0)1423 529333
events@hg3.co.uk
